TY  - GEN
AU  - Mathew,Paul
AU  - Logothetis,Christopher J
AU  - Dieringer,Pauline Y
AU  - Chen,Isan
AU  - Pagliaro,Lance C
AU  - Bekele,Benjamin N
AU  - Zhou,Xian
AU  - Daliani,Danai D
TI  - Thalidomide/estramustine/paclitaxel in metastatic androgen-independent prostate cancer
SN  - 1558-7673
PY  - 2007///0215
KW  - Adenocarcinoma
KW  - drug therapy
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Bridged-Ring Compounds
KW  - adverse effects
KW  - Disease Progression
KW  - Estramustine
KW  - administration & dosage
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Neoplasms, Hormone-Dependent
KW  - Paclitaxel
KW  - Prostate-Specific Antigen
KW  - blood
KW  - Prostatic Neoplasms
KW  - Survival Rate
KW  - Taxoids
KW  - Thalidomide
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.3816/CGC.2006.n.031
ER  -